ID: ALA5278512

Max Phase: Preclinical

Molecular Formula: C18H16N2O5

Molecular Weight: 340.34

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1c(O)c(C)c(O)c2c1OC1=CC(=O)c3c(n[nH]c3C)[C@@]12C

Standard InChI:  InChI=1S/C18H16N2O5/c1-6-14(23)12(8(3)21)16-13(15(6)24)18(4)10(25-16)5-9(22)11-7(2)19-20-17(11)18/h5,23-24H,1-4H3,(H,19,20)/t18-/m0/s1

Standard InChI Key:  LWLIMHGDEFGWAK-SFHVURJKSA-N

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 340.34Molecular Weight (Monoisotopic): 340.1059AlogP: 2.42#Rotatable Bonds: 1
Polar Surface Area: 112.51Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.54CX Basic pKa: 1.72CX LogP: 2.16CX LogD: 1.93
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: 1.45

References

1. Gunawan GA, Gimła M, Gardiner MG, Herman-Antosiewicz A, Reekie TA..  (2023)  Divergent reactivity of usnic acid and evaluation of its derivatives for antiproliferative activity against cancer cells.,  79  [PMID:36652792] [10.1016/j.bmc.2023.117157]

Source